Access cutting-edge systemic amyloidosis treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access systemic amyloidosis specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic amyloidosis treatment provided free
This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02. AT-02 is an investigational medicinal product being developed to treat systemic amyloidosis.
Sponsor: Attralus, Inc.
Check if you qualify for this systemic amyloidosis clinical trial in Portland, OR
If you're searching for systemic amyloidosis treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.